Strategic Partnerships for Autophagy Activator Development

(Overview)

We developed novel autophagy activators which demonstrate promising biological and pharmacological properties.

These compounds are currently under preclinical evaluation and show potential for therapeutic applications related to autophagy regulation.

(Key Highlights)

Strong Autophagy Activation：

Demonstrated significant autophagy activation in HeLa cell assays.

Excellent Oral Absorption：

Achieved favorable pharmacokinetic profiles in both rats and mice following oral administration.

No Significant Safety Concerns：

No significant safety concerns were identified in in vitro safety tests.

(Partnership Opportunity)

We are actively seeking strategic business partners to collaborate with us in the following areas:

・Joint research and development

・Licensing and commercialization

・Clinical development

We are actively seeking a strategic partner who can develop our compounds into medicines.